AP NEWS

United States Gaucher’s Disease Market and Competitive Landscape 2018 - ResearchAndMarkets.com

October 5, 2018

DUBLIN--(BUSINESS WIRE)--Oct 5, 2018--The “US Gaucher’s Disease Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

US Gaucher’s Disease Market and Competitive Landscape - 2018, provides comprehensive insights into Gaucher’s Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Gaucher’s Disease market size and drug sales. This research also provides insights into Gaucher’s Disease epidemiology and late stage pipeline.

The research is classified into following sections - Gaucher’s Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Gaucher’s Disease pipeline insights covering late stage clinical trials pipeline; Gaucher’s Disease prevalence trends by countries; Gaucher’s Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes the market - USA.

Research Scope:

Gaucher’s Disease pipeline: Find out the drugs in clinical trials for Gaucher’s Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Gaucher’s Disease epidemiology: Find out the prevalence of Gaucher’s Disease in US; prevalence forecast to 2023 Gaucher’s Disease products: Identify key products marketed and prescribed for Gaucher’s Disease by brand name, by molecule, by company, by branded / generic, in US Gaucher’s Disease market size: Find out the market size for Gaucher’s Disease drugs in US; Find out how the market advanced from 2014 Gaucher’s Disease drug sales: Find out the sales of Gaucher’s Disease drugs in US Gaucher’s Disease drugs sales forecast: Sales forecast for Gaucher’s Disease drugs to 2023 in US Gaucher’s Disease market share analysis: Find out the market shares of Gaucher’s Disease drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/pdft6d/united_states?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181005005324/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrine and Metabolic Disorders Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/05/2018 10:44 AM/DISC: 10/05/2018 10:44 AM

http://www.businesswire.com/news/home/20181005005324/en

AP RADIO
Update hourly